Table 1.
Parameter | SLE patients (n = 32) |
---|---|
Demographic data | Mean ± SD |
Age (years) | 37.9 ± 14.4 |
Disease duration (years) | 9.9 ± 7.9 |
Gender (female/male) | 30/2 |
SLEDAI | 7.7 ± 6.1 |
Clinical manifestations | No (%) |
Malar rash | 10 (31.3) |
Discoid rash | 11 (34.4) |
Phototosensitivity | 18 (56.3) |
Oral ulcers | 14 (43.8) |
Arthritis | 9 (28.1) |
Serositis | 4 (12.5) |
Renal disorders | 16 (50) |
Neurological disorders | 12 (37.5) |
Haematological disease | 7 (21.9) |
Immunological disorders | 18 (56.3) |
Anti-nuclear Ab | 32 (100) |
Anti-dsDNA Ab | 13 (40.6) |
Anti-Smith Ab | 7 (21.9) |
Anti-snRNP Ab | 7 (21.9) |
Anti-Ro Ab | 4 (12.5) |
Anti-La Ab | 6 (18.8) |
Anti-Scl-70 Ab | 10 (31.3) |